Published in Am J Physiol on January 01, 1979
Expression of AT2 receptors in the developing rat fetus. J Clin Invest (1991) 1.89
Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest (1995) 1.72
Effect of cortisol on blood pressure and the renin-angiotensin system in fetal sheep during late gestation. J Physiol (2000) 0.89
Role of cortisol in the ontogenic control of pulmonary and renal angiotensin-converting enzyme in fetal sheep near term. J Physiol (2000) 0.84
Antenatal maternal hypoxic stress: adaptations in fetal lung Renin-Angiotensin system. Reprod Sci (2010) 0.84
Antenatal maternal low protein diet: ACE-2 in the mouse lung and sexually dimorphic programming of hypertension. BMC Physiol (2015) 0.75
Common mechanism of toxicity: a case study of organophosphorus pesticides. Toxicol Sci (1998) 2.08
Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol (2006) 1.71
Enhancement of renal blood flow by furosemide. J Pharmacol Exp Ther (1968) 1.34
Effects of several saluretic-diuretic agents on renal hemodynamics. J Pharmacol Exp Ther (1966) 1.27
Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res (2001) 1.25
Angiotensin II in arterial and renal venous plasma and renal lymph in the dog. J Clin Invest (1971) 1.15
Specificity of the inhibitory effect of "uremic" serum on p-aminohippurate transport. Proc Soc Exp Biol Med (1968) 1.14
Influence of probenecid and alterations in acid-base balance of the saluretic activity of furosemide. J Pharmacol Exp Ther (1965) 1.13
Lack of correlation between natriuretic activity and inhibition of renal Nak-activated ATPase. Proc Soc Exp Biol Med (1965) 1.13
Doxorubicin-induced persistent oxidative stress to cardiac myocytes. Toxicol Lett (2001) 1.10
Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol Sci (2002) 1.07
Renin release: relation to renal sodium load and dissociation from hemodynamic changes. Circ Res (1968) 1.07
Natriuretic effect of furosemide after inhibition of prostaglandin synthetase. J Pharmacol Exp Ther (1976) 1.06
Age-related nephropathy in laboratory rats. FASEB J (1988) 1.01
Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res B Dev Reprod Toxicol (2005) 0.98
Effects of asphyxia on cardiac output and organ blood flow in the newborn piglet. Pediatr Res (1978) 0.95
Perinatal renal pharmacology. Annu Rev Pharmacol Toxicol (1979) 0.94
Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim Biophys Acta (1999) 0.93
Mechanism of natriuretic action of bradykinin. Am J Physiol (1969) 0.93
Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes. Toxicology (2011) 0.92
Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin. Biochim Biophys Acta (1997) 0.92
Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration. Toxicol Appl Pharmacol (1994) 0.91
Control of renin secretion in the dog. Effects of furosemide on the vascular and macula densa receptors. Circ Res (1975) 0.91
Concomitant dietary exposure to polychlorinated biphenyls and polybrominated biphenyls: tissue distribution and arylhydrocarbon hydroxylase activity in lactating rats. Toxicol Appl Pharmacol (1979) 0.90
Cisplatin nephrotoxicity: role of filtration and tubular transport of cisplatin in isolated perfused kidneys. Toxicology (1987) 0.90
Enzymes of renal origin in urine as indicators of nephrotoxicity. Toxicol Appl Pharmacol (1977) 0.90
Renin secretion by rat kidney slices in vitro. Proc Soc Exp Biol Med (1974) 0.89
Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy. Toxicol Appl Pharmacol (2002) 0.89
Benzoquinone inhibits the voltage-dependent induction of the mitochondrial permeability transition caused by redox-cycling naphthoquinones. Toxicol Appl Pharmacol (1997) 0.88
The effect of peroxisome proliferators on mitochondrial bioenergetics. Toxicol Sci (1999) 0.88
Effects of environmental chemicals on kidney metabolism and function. Kidney Int (1980) 0.88
Age-related differences in susceptibility to renal ischemia in rats. Toxicol Appl Pharmacol (1987) 0.88
A conceptual framework for predicting the toxicity of reactive chemicals: modeling soft electrophilicity. SAR QSAR Environ Res (2006) 0.87
Effect of monocrotaline ingestion on liver, kidney, and lung of rats. Toxicol Appl Pharmacol (1981) 0.87
Metabolism and pharmacokinetics of acetaminophen in a severely poisoned young child. J Pediatr (1984) 0.87
Differential mechanisms of cell killing by redox cycling and arylating quinones. Arch Toxicol (1996) 0.86
Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin. J Mol Cell Cardiol (1996) 0.86
Role of the renin-angiotensin system in hypertension after coarctation of the aorta. J Lab Clin Med (1984) 0.86
Determination of 8-hydroxydeoxyguanosine in biological tissue by liquid chromatography/electrospray ionization-mass spectrometry/mass spectrometry. Rapid Commun Mass Spectrom (1996) 0.86
Transluminal arterial dilation of a postsurgical stenosis of renal artery implant in a child with recurrent hypertension. Pediatrics (1982) 0.86
Tamoxifen inhibits induction of the mitochondrial permeability transition by Ca2+ and inorganic phosphate. Toxicol Appl Pharmacol (1998) 0.86
Carcinogenicity study of auranofin, an orally administered gold compound, in mice. Fundam Appl Toxicol (1988) 0.85
The effect of vasodilator drugs on the noradrenaline constrictor response in the isolated mesenteric artery. Can J Physiol Pharmacol (1969) 0.85
Angiotensin-converting enzyme in developing lung and kidney. Am J Physiol (1978) 0.85
cis-Dichlorodiammineplatinum nephrotoxicity: time course and dose response of renal functional impairment. Toxicol Appl Pharmacol (1981) 0.85
Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction. Cardiovasc Toxicol (2005) 0.85
A positive correlation between natriuresis and inhibition of renal Na-K adenosine triphosphatase by ouabain. Proc Soc Exp Biol Med (1969) 0.85
Continuous monitoring of mitochondrial membrane potential in hepatocyte cell suspensions. J Pharmacol Toxicol Methods (1996) 0.85
Intrarenal secretion of renin in the dog: effect of furosemide. Am J Physiol (1973) 0.84
Depletion by 1,2-dibromoethane, 1,2-dibromo-3-chloropropane, tris(2,3-dibromopropyl)phosphate, and hexachloro-1,3-butadiene of reduced non-protein sulfhydryl groups in target and non-target organs. Biochem Pharmacol (1981) 0.84
Nephrotoxicity of hexachloro-1,3-butadiene in the mouse: the effect of age, sex, strain, monooxygenase modifiers, and the role of glutathione. Toxicol Appl Pharmacol (1984) 0.84
Mechanism of renal handling of angiotensin II in the dog. Circ Res (1973) 0.84
Nephrotoxicity of paraquat in mice. Toxicol Appl Pharmacol (1975) 0.83
Molecular determinants of the species-selective inhibition of brain acetylcholinesterase. Toxicol Appl Pharmacol (1990) 0.83
In vitro metabolism of C-14-labeled amino acids by sheep kidney cortex and medulla. Am J Physiol (1966) 0.83
Differential mechanisms of induction of the mitochondrial permeability transition by quinones of varying chemical reactivities. Toxicol Appl Pharmacol (1995) 0.83
Cardiac glycoside sensitivity of (Na + +K + )-activated ATPase in new-born rats. Res Commun Chem Pathol Pharmacol (1972) 0.83
Effects of aminoglycosides on glomerular permeability, tubular reabsorption, and intracellular catabolism of the cationic low-molecular-weight protein lysozyme. Toxicol Appl Pharmacol (1983) 0.83
Species-related differences in the inhibition of brain acetylcholinesterase by paraoxon and malaoxon. Toxicol Appl Pharmacol (1987) 0.83
Nephrotoxicity of Hexachloro-1:3-butadiene in the rat: the effect of age, sex, and strain. Toxicol Appl Pharmacol (1983) 0.82
Renal ultrastructural and biochemical injuries induced by aminoglycosides. Environ Health Perspect (1984) 0.82
Postnatal development of the renin-angiotensin system in rats. Am J Physiol (1980) 0.82
Release of vasoactive materials from the kidney by diuretics. J Clin Pharmacol (1977) 0.82
Effect of furosemide on renal hilar lymph flow. Arch Int Pharmacodyn Ther (1976) 0.82
Selective activation of the sodium-independent, cyclosporin A-sensitive calcium pore of cardiac mitochondria by doxorubicin. Toxicol Appl Pharmacol (1993) 0.82
Effect of 2,3,7,8-tetrachlorodibenzo-rho-dioxin on renal function in the rat. J Toxicol Environ Health (1976) 0.81
Effects of gentamicin on renal function in isolated perfused kidneys from male and female rats. Toxicol Lett (1985) 0.81
Doxorubicin-induced thiol-dependent alteration of cardiac mitochondrial permeability transition and respiration. Biochemistry (Mosc) (2006) 0.81
Acetaminophen nephrotoxicity in the rat. II. Strain differences in nephrotoxicity and metabolism of p-aminophenol, a metabolite of acetaminophen. Toxicol Appl Pharmacol (1983) 0.80
Mechanism of chloroform nephrotoxicity. II. In vitro evidence for renal metabolism of chloroform in mice. Toxicol Appl Pharmacol (1983) 0.80
Mechanism of prostaglandin E(2) stimulation of renin secretion. Proc Soc Exp Biol Med (1978) 0.80
Potentiation of hepatic and renal toxicity of various compounds by prior exposure to polybrominated biphenyls. Environ Health Perspect (1978) 0.80
Effects of polybrominated biphenyls on kidney function and activity of renal microsomal enzymes. Environ Health Perspect (1978) 0.80
Analysis of gentamicin uptake by rat renal cortical slices. Toxicol Appl Pharmacol (1978) 0.80
Nephrotoxicity of chloroform: metabolism to phosgene by the mouse kidney. Toxicol Appl Pharmacol (1984) 0.80
Developmental aspects of renal pharmacology. Pharmacol Ther (1982) 0.80
Urinary excretion of renin in the dog: effect of changes in plasma renin. J Pharmacol Exp Ther (1983) 0.80
Effects of age and sex on hexachloro-1,3-butadiene toxicity in the Fischer 344 rat. Life Sci (1983) 0.80
Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney. J Pharmacol Exp Ther (1986) 0.80
Role of hemodynamic changes in the effect of furosemide on the renal concentrating mechanism. Eur J Pharmacol (1970) 0.80
Differential destruction of cytochrome P-450-dependent monooxygenases in rat and mouse kidney following hexachloro-1:3-butadiene administration. Mol Pharmacol (1983) 0.80
Hepatic and renal conjugation (Phase II) enzyme activities in young adult, middle-aged, and senescent male Sprague-Dawley rats. Proc Soc Exp Biol Med (1991) 0.79
Acetaminophen nephrotoxicity in the rat. I. Strain differences in nephrotoxicity and metabolism. Toxicol Appl Pharmacol (1983) 0.79
Mechanism of chloroform nephrotoxicity. III. Renal and hepatic microsomal metabolism of chloroform in mice. Toxicol Appl Pharmacol (1984) 0.79
Role of alterations in renal hemodynamics in the natriuretic action of glucagon. Arch Int Pharmacodyn Ther (1970) 0.79
Effects of indomethacin on furosemide-induced changes in renal blood flow. Proc Soc Exp Biol Med (1975) 0.79
Lipid peroxidation: a possible mechanism of cephaloridine-induced nephrotoxicity. Toxicol Appl Pharmacol (1983) 0.79
Maturation of renal organic acid transport: substrate stimulation by penicillin. Science (1969) 0.79
Paraquat concentration and renal function in mice fed purified and cereal-based diets. Drug Nutr Interact (1983) 0.79
The effects of cisplatin and other divalent platinum compounds on glucose metabolism and pancreatic endocrine function. Toxicol Appl Pharmacol (1983) 0.79